Adherence to therapy for patients with glaucoma or ocular hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13706134

Enrollment

120

Registered

2006-09-29

Start date

2005-04-21

Completion date

Unknown

Last updated

2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases: Glaucoma Eye Diseases Glaucoma

Interventions

Added April 2008: This pilot study has three parts. Part 1: A Cochrane Systematic Review entitled, ?Interventions for improving adherence to ocular hypotensive therapy?. Protocol for the Cochrane re

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Added April 2008: Patients newly prescribed ocular hypotensive eye drops with a diagnosis of open angle glaucoma, normal tension glaucoma, pseudo-exfoliation glaucoma, pigment dispersion glaucoma or ocular hypertension.

Exclusion criteria

Exclusion criteria: Added April 2008: Patients unable to give informed consent or patients already prescribed a complicated drop regime for another eye condition.

Design outcomes

Primary

Measure	Time frame
Persistency of treatment during the first year of therapy will be the main outcome measure. Persistency will be measured by comparing the number of doses dispensed and the number prescribed, taking into account that UK prescriptions are valid for 28 days.	—

Secondary

Measure	Time frame
Added April 2008: Adherence to therapy, illness perceptions, beliefs about medicines and patient enablement. Secondary outcomes will be measured via validated questionnaires during patient interviews at the end of the study.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026